tiprankstipranks
Ligand Pharmaceuticals Inc (LGND)
NASDAQ:LGND
Want to see LGND full AI Analyst Report?

Compare Ligand Pharma (LGND) vs. Competitors

841 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Ligand Pharma
$231.82
$4.36B
-74.37
107.54%
7 Buy
0 Hold
0 Sell
Strong Buy
Apellis Pharmaceuticals
$40.90
132.20%
2 Buy
13 Hold
0 Sell
Hold
Scholar Rock Holding
$49.96
$5.80B
-14.83
53.39%
15 Buy
0 Hold
0 Sell
Strong Buy
Crinetics Pharmaceuticals
$41.00
$3.82B
-7.39
15.62%
10 Buy
0 Hold
0 Sell
Strong Buy
Kymera Therapeutics
$87.71
$6.63B
-29.33
156.52%
16 Buy
0 Hold
0 Sell
Strong Buy
MoonLake Immunotherapeutics
$18.34
$1.26B
-4.76
-57.67%
10 Buy
2 Hold
2 Sell
Moderate Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
LGND
Ligand Pharma
217.75
115.30
112.54%
APLS
Apellis Pharmaceuticals
41.03
23.61
135.53%
SRRK
Scholar Rock Holding
48.38
17.66
57.49%
CRNX
Crinetics Pharmaceuticals
36.27
6.32
21.10%
KYMR
Kymera Therapeutics
80.65
50.52
167.67%
MLTX
MoonLake Immunotherapeutics
17.05
-21.49
-55.76%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts